Search results
In the spotlight. Roche has established a multi-lingual global hotline (tel: +36 146 182 58; WhatsApp +36 707 177 394) and an email address (patientcare@roche.com) for patients and healthcare providers in or from Ukraine. We will do our best to provide everyone who is in need with the appropriate information and support.
Roche granted FDA Breakthrough Device Designation for blood test measuring Lp (a) — a key marker for hereditary cardiovascular risk. Through our collaboration with Amgen, Roche is paving the way to make elevated Lp (a) an actionable biomarker.
About Roche. Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients ...
Catch a glimpse of our future fully automated, standardized liquid chromatography-mass spectrometry (LC-MS) solution: the cobas® Mass Spec. Learn More. Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases. About Roche Diagnostics.
Roche. F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
At Roche Diagnostics, we develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the globe In-vitro tests Our core business is the discovery, development and manufacturing of in vitro tests for the diagnosis of various diseases that include cancer, diabetes, Covid-19, hepatitis, human ...
